CIK 0001683553 · Non-accelerated filer<br>Smaller reporting company
SPRUCE BIOSCIENCES, INC.
Sign in to watch- Ticker
- SPRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812154263
- Phone
- (415) 655-4168
- Business address
- 611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-27 | Quartel Adrian W Chief Medical Officer | Grant or award · Restricted Stock Units | +13,000 | 13,000 | ||
| 2026-06-30 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Grant or award | +266 | $4.53 | $1K | 19,270 |
| 2026-05-21 | Walbert Keli Director | Grant or award · Stock Option (Right to Buy) | +1,700 | 1,700 | ||
| 2026-05-21 | Barretto-Ko Percival Director | Grant or award · Stock Option (Right to Buy) | +1,700 | 1,700 | ||
| 2026-05-21 | SIMPSON CAMILLA V Director | Grant or award · Stock Option (Right to Buy) | +1,700 | 1,700 | ||
| 2026-05-21 | GREY MICHAEL G Executive Chairman | Grant or award · Stock Option (Right to Buy) | +1,700 | 1,700 | ||
| 2026-05-21 | SPIEGELMAN DANIEL K Director | Grant or award · Stock Option (Right to Buy) | +1,700 | 1,700 | ||
| 2026-03-09 | Hooks Corwin Dale Chief Commercial Officer | Grant or award · Restricted Stock Units | +11,000 | 11,000 | ||
| 2025-12-31 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Grant or award | +4,690 | $4.53 | $21K | 19,004 |
| 2025-12-15 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise | +1,480 | 14,478 | ||
| 2025-12-15 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −752 | $80.67 | $61K | 13,726 |
| 2025-12-15 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise | +1,196 | 14,922 | ||
| 2025-12-15 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −608 | $80.67 | $49K | 14,314 |
| 2025-12-15 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −1,480 | 1,480 | ||
| 2025-12-15 | Szwarcberg Javier B. CHIEF EXECUTIVE OFFICER | Option exercise · Restricted Stock Units | −1,196 | 2,392 | ||
| 2025-12-15 | Gharib Samir M. PRESIDENT AND CFO | Option exercise | +496 | 8,112 | ||
| 2025-12-15 | Gharib Samir M. PRESIDENT AND CFO | Shares withheld for taxes | −178 | $80.67 | $14K | 7,934 |
| 2025-12-15 | Gharib Samir M. PRESIDENT AND CFO | Option exercise | +513 | 8,447 | ||
| 2025-12-15 | Gharib Samir M. PRESIDENT AND CFO | Shares withheld for taxes | −184 | $80.67 | $15K | 8,263 |
| 2025-12-15 | Gharib Samir M. PRESIDENT AND CFO | Option exercise · Restricted Stock Units | −496 | 497 |
Page 1 of 12 · 231 trades